Cargando…
Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162917/ https://www.ncbi.nlm.nih.gov/pubmed/35513704 http://dx.doi.org/10.1038/s41375-022-01588-z |
| _version_ | 1784719815228784640 |
|---|---|
| author | Adamia, Sophia Bhatt, Shruti Wen, Kenneth Chyra, Zuzana Fell, Geoffrey G. Tai, Yu-Tzu Pioso, Marissa S. Abiatari, Ivane Letai, Anthony Dorfman, David M. Hideshima, Teru Anderson, Kenneth C. |
| author_facet | Adamia, Sophia Bhatt, Shruti Wen, Kenneth Chyra, Zuzana Fell, Geoffrey G. Tai, Yu-Tzu Pioso, Marissa S. Abiatari, Ivane Letai, Anthony Dorfman, David M. Hideshima, Teru Anderson, Kenneth C. |
| author_sort | Adamia, Sophia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9162917 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91629172022-06-05 Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma Adamia, Sophia Bhatt, Shruti Wen, Kenneth Chyra, Zuzana Fell, Geoffrey G. Tai, Yu-Tzu Pioso, Marissa S. Abiatari, Ivane Letai, Anthony Dorfman, David M. Hideshima, Teru Anderson, Kenneth C. Leukemia Correction Nature Publishing Group UK 2022-05-05 2022 /pmc/articles/PMC9162917/ /pubmed/35513704 http://dx.doi.org/10.1038/s41375-022-01588-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Adamia, Sophia Bhatt, Shruti Wen, Kenneth Chyra, Zuzana Fell, Geoffrey G. Tai, Yu-Tzu Pioso, Marissa S. Abiatari, Ivane Letai, Anthony Dorfman, David M. Hideshima, Teru Anderson, Kenneth C. Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma |
| title | Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma |
| title_full | Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma |
| title_fullStr | Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma |
| title_full_unstemmed | Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma |
| title_short | Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma |
| title_sort | author correction: combination therapy targeting erk1/2 and cdk4/6i in relapsed refractory multiple myeloma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162917/ https://www.ncbi.nlm.nih.gov/pubmed/35513704 http://dx.doi.org/10.1038/s41375-022-01588-z |
| work_keys_str_mv | AT adamiasophia authorcorrectioncombinationtherapytargetingerk12andcdk46iinrelapsedrefractorymultiplemyeloma AT bhattshruti authorcorrectioncombinationtherapytargetingerk12andcdk46iinrelapsedrefractorymultiplemyeloma AT wenkenneth authorcorrectioncombinationtherapytargetingerk12andcdk46iinrelapsedrefractorymultiplemyeloma AT chyrazuzana authorcorrectioncombinationtherapytargetingerk12andcdk46iinrelapsedrefractorymultiplemyeloma AT fellgeoffreyg authorcorrectioncombinationtherapytargetingerk12andcdk46iinrelapsedrefractorymultiplemyeloma AT taiyutzu authorcorrectioncombinationtherapytargetingerk12andcdk46iinrelapsedrefractorymultiplemyeloma AT piosomarissas authorcorrectioncombinationtherapytargetingerk12andcdk46iinrelapsedrefractorymultiplemyeloma AT abiatariivane authorcorrectioncombinationtherapytargetingerk12andcdk46iinrelapsedrefractorymultiplemyeloma AT letaianthony authorcorrectioncombinationtherapytargetingerk12andcdk46iinrelapsedrefractorymultiplemyeloma AT dorfmandavidm authorcorrectioncombinationtherapytargetingerk12andcdk46iinrelapsedrefractorymultiplemyeloma AT hideshimateru authorcorrectioncombinationtherapytargetingerk12andcdk46iinrelapsedrefractorymultiplemyeloma AT andersonkennethc authorcorrectioncombinationtherapytargetingerk12andcdk46iinrelapsedrefractorymultiplemyeloma |